Law doesn’t always adequately address unauthorized uses of individuals’ DNA. Ethics can help establish legal privacy protections that work.

Dr Charles Binkley joins Ethics Talk to discuss his article, coauthored with Michael Politz and Dr Brian Green: "Who, If Not the FDA, Should Regulate Implantable Brain-Computer Interface Devices?"

COVID-19 underscores historical precedent for fear-driven responses that disregard autonomy among persons with low income who are also persons of color.

This drawing considers masks’ transformation from an evidence-based public health measure to a political symbol during the 2020 COVID-19 pandemic.

This article features a digital photo painting of a clinician during the COVID-19 pandemic.

In the 1910s, the American Medical Association fought quackery promoted in pamphlets for drugs and treatments for everything from teething to epilepsy.

Minimizing and managing risks of ENMs means considering whether and when existing legal frameworks offer sufficient protection.

Nanoscale products pose ethical, legal, and policy challenges to governing the use of products that integrate multiple mechanisms of therapeutic action.

Responding to patients violating US health commerce regulations can be critical when they buy and use unproven interventions.

Transnational monitoring efforts should focus on safety, defining standard of care, and promoting just access to innovation.